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Abstract 
Airborne disease transmission is a prominent problem facing an increasingly mobilized 
world. It involves small droplets (bioaerosols) containing pathogens which form in the lungs and 
are expelled to the environment, where they may persist in the air until inhaled by others. 
Conceptually, there are two basic approaches to preventing transmission: protect the potential 
target, or eliminate the source. To this end, the effectiveness of modifying mucus viscoelasticity, 
through cation exposure, to prevent pathogen transport via bioaerosols was investigated.  
In vitro models were developed to explore the proposed mechanisms for droplet 
formation: shear-induced surface-wave instabilities in the airway lining fluid (ALF) of the upper 
airways; and film formation during the re-opening of collapsed bronchioles in the lower airways. 
Droplet formation during tidal breathing was shown to be an inhalation process for both upper 
and lower airway models, and the bifurcation angle of the first bronchi was relevant to the upper 
airway model. A simulated cough system was also developed and produced the largest number 
of droplets.  
COPD sputum viscoelasticity was characterized and its response to cation presence 
measured: low concentrations of calcium resulted in increased complex modulus and decreased 
loss tangent (indicating increased fluid stiffness resulting from higher elasticity). Higher 
iv 
 
concentrations of calcium had the reverse effect. Using the cough system, calcium treated (low 
concentration) and untreated sputum were compared: treated sputum produced fewer droplets. 
Droplet concentration (number per liter of air) correlated well with the magnitude of the complex 
modulus.  
Once the reduction in total droplets was established, pathogen transport experiments, in 
which human rhinovirus (HRV) was added to calcium-treated and untreated COPD sputum, were 
performed. Cell culture media was exposed to cough-air from the samples and then placed on 
HRV-sensitized HeLa cells, which were then monitored for cell death. Cell death was observed 
for untreated sputum samples, but not for cation-treated samples, indicating that reducing 
bioaerosol formation (through cationic modification of mucus viscoelasticity) prevented airborne 
transport of the virus.  
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Chapter 1: Airborne infectious disease transmission 
Introduction: 
Transmissible diseases are a basic part of existence. They occur in many forms and 
varieties, but the most basic description would involve an invasive and foreign particle entering a 
host and replicating, typically to the detriment of the host. There are many routes or vectors 
which a particle can take to enter the body – for example, it may directly enter the bloodstream 
through cuts or other wounds, or it may colonize the gastrointestinal or pulmonary tracts after 
being swallowed or inhaled – the exact mechanism of infection will depend on the specific 
pathogen. However, the simple fact that, before an infection can begin, a pathogenic organism 
must first reach its target destination makes preventing exposure an immediate and obvious route 
to halting the spread of these infectious diseases.  
At the simplest level, this can be accomplished in one of two ways: either creating 
“barriers” around the destination, or preventing the pathogen from escaping from the source. The 
former is frequently employed through the use of masks, gloves, antibacterial sprays and washes 
but it remains a passive defense which does not always eliminate the pathogen from the 
environment. It thus becomes only a question of time until the “barrier” is circumvented (through 
mistakes, negligence, ineffectiveness or even adaptation).As long as the pathogen is in the 
environment, the risk of infection remains. Targeting the source is therefore more desirable, 
however it is also more difficult – pathogens are transported within bodily fluids (blood, mucus, 
etc.) and are shed from the body in a variety of ways, many of which are invisible to the naked 
eye. Furthermore, the exact route to infection is not uniform across all pathogens. 
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In 2004 a study conducted on the SARS outbreak in Hong Kong and published in the 
New England Journal of Medicine by Ignatius Yu et al.2 concluded that airborne transmission 
was the likely route for the spread of the virus. Chad Roy (U.S. Army Medical Research Institute 
of Infectious Diseases) and Donald Milton (Harvard School of Public Health) cited Yu’s study in 
an article3 in the same publication to highlight the need for a fundamental shift in how doctors 
understood and approached the relationship between infectious disease and airborne 
transmission. Claiming the traditionally held view that diseases either were “true” airborne 
infections or not airborne infections at all was too limited, and did not lead to “useful thinking” 
about the problem, they proposed a new classification system for airborne diseases as “obligate, 
preferential, or opportunistic.” Obligate airborne diseases transmit only through aerosols; 
preferential airborne diseases transmit primarily via aerosols, but may spread in other ways as 
well (such as direct contact); opportunistic airborne diseases may transmit via aerosol, but 
primarily spread through other means.  
Roy and Milton pointed out the need for a deeper understanding of airborne transmission, 
specifically in regards to hospitals and other indoor settings (schools, airplanes, etc.) while citing 
the transmission of SARS in hospital waiting rooms. They believed their new categorization 
system would provide a more nuanced way of thinking about disease transmission, specifically 
in regards to prevention. For example, in preferential or opportunistic airborne disease scenarios, 
hand-washing alone might reduce the probability for transmission, but it would not eliminate it – 
a combination of preventative measures would be necessary – but due to observed decreases in 
transmission, the additional measures might not be implemented. Furthermore, some measures 
thought to reduce bioaerosol transmission, such as the use of surgical masks, have been shown to 
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be ineffective for any but the largest droplets4. Hence, further research into airborne disease 
transmission and prevention is vital. 
Historically, airborne transmission has been thought to be the result of pathogen-laden, 
large-diameter droplets expelled via coughing, sneezing or talking. In the 1940s, J. P. Duguid 
(Edinburgh University) performed a series of experiments attempting to clarify the role of 
droplet spray in infection transmission5. Patients with a confirmed infection of either haemolytic 
streptococcus, diphtheria or tuberculosis were asked to perform different breathing maneuvers 
(coughing, sneezing, talking) while a microscope slide or culture plate was held in front of them 
to collect expelled droplets by impingement. The slide or plate was then analyzed for pathogen 
presence. The study acknowledged that only the largest droplets would be collected on the plates, 
but claimed that the majority of “pathogenic organisms were contained in the large droplets.” 
This claim was made without reference to any supporting evidence, and reflects the prevailing 
opinions of the time. These opinions were the result of a simple fact: there were no methods for 
detecting smaller droplets (aerosols), and therefore no one was aware of how many were being 
produced. With the development and proliferation of optical methods for measuring small and 
very small airborne particles (nanometers to microns in scale) in the 1980s and 1990s, research 
began on the size and number of expelled droplets.  
In 1997, R. Papineni and F. Rosenthal (Purdue University) published a study on the 
number and size distribution of droplets in the exhaled breath of healthy humans7. Not only did 
they confirm the presence of small droplets (less than 5 microns in diameter), but they found that 
these droplets were present in numbers that were significantly greater than those of larger 
droplets (more than an order of magnitude difference). 
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pathogens remain infectious (i.e. pathogen lifetime). Droplets which settle will contaminate 
nearby surfaces, whereas bioaerosols persist in the air and may be convectively transported 
larger distances. Both these routes can lead to exposure (stage IV), either through contact with 
contaminated surfaces or through inhaled bioaerosols depositing directly in the lungs. 
Prevention methods have largely focused on stage III and IV, either through treating the 
environment (washing hands, cleaning exposed surfaces, etc.) or erecting barriers to prevent 
inhalation (i.e. facemasks). However in 2004, David Edwards (Harvard University) et al. 
published a study in the Proceedings of the National Academy of Science8 in which they 
screened healthy human subjects for exhaled droplets both before and after treatment with 
nebulized isotonic saline. This novel approach sought to address the issue of airborne 
transmission by targeting the bioaerosol origin (stage I). They identified a portion of the 
population as “super-producers” – individuals who expelled significantly greater droplet amounts 
compared to the rest of the population. Treatment of these individuals with nebulized saline 
subsequently reduced the number of droplets they expelled. These results were replicated with 
Holstein bull calves in a subsequent study (R. Clarke et al., 2005, American Journal of Infection 
Control10). Further investigation of this effect was carried out by W. Watanabe et al. (2007, 
Journal of Colloid and Interface Science)9 and indicated that inhaled salt water altered the 
viscoelasticity of airway mucus through mucin charge-shielding, thereby stabilizing the interface 
and resulting in reduced droplet formation.  
Debate has arisen over the location and mechanism of bioaerosol formation within the 
pulmonary system. The pulmonary system (Figure 1.4) is commonly divided into two regions: 
the upper airways (which consists of the naso-pharynx, trachea, and bronchi) and the lower 
airways (bronchioles and alveoli)14.While the traditional view has been that droplets are formed 
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through shear forces acting on the surface of the airway lining fluid in the upper airways (as 
demonstrated computationally by J. Moriarty and J. Grotberg in their 1999 publication)11, an 
alternative method involving film rupture in the lower airways has also been proposed (with 
supporting research performed by G. Johnson and L. Morawska published in 2009 and 
2010)12,13.As the two mechanisms differ significantly, the relevant physical properties are likely 
to differ as well; hence any investigation into bioaerosol prevention must consider both of these 
approaches. 
 
 
Figure 1.4: The pulmonary system14 
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Thesis research: 
The purpose of my thesis will be to investigate the small droplet hypothesis of airborne 
disease transmission (which states that small aerosols generated in the airways and expelled to 
the environment can contain pathogens which lead to infection when inhaled), particularly with 
the aim of preventing such transmission by targeting droplet origins (specifically through the use 
of cationic agents to alter the physical properties of airway mucus). These goals will be 
accomplished by empirical examination of the following hypotheses, which were developed 
based on literature review and empirical results (to be demonstrated in subsequent chapters): 
i) Droplet generation during tidal breathing can occur in both the 
upper airways (via surface shear) and lower airways (via film 
rupture) during inhalation, and will vary with bifurcation angle 
in the upper airways. 
ii) Mucus viscoelasticity will influence droplet formation by shear 
forces, with increased stiffness yielding fewer droplets in total. 
iii) Reducing the number of bioaerosols generated decreases the 
probability of airborne pathogen transport, and therefore the 
transmission of infection. 
This research will yield a deeper understanding of bioaerosol formation and airborne 
disease transmission. It will clarify the influence of cations on mucus viscoelasticity, and provide 
guidelines regarding cation concentration which will have applicable ramifications in 
determining effective dosages. Finally, bench-top tools will be developed to enable more rapid 
experimentation on the mechanisms of bioaerosol formation.
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Chapter 2: Mechanisms of bioaerosol formation and transport  
Introduction: 
 In order to investigate airborne transmission through bioaerosols, as discussed in chapter 
1, a review of existing literature and theory regarding the mechanisms of formation and transport 
is necessary. Bioaerosols (biological aerosols) are small, airborne droplets containing pathogens 
and other biological material which are generated in the lungs1. They are formed from the airway 
lining fluid (ALF) which is a protective coating covering the entire pulmonary system. As such, 
the material properties of the ALF will influence the mechanics of droplet formation. The 
structure of the pulmonary system will also be relevant, especially in regards to the type of 
breath-action (coughing versus tidal breathing) as well as the location of droplet formation.  
Some controversy over the exact mechanism and origin of droplet formation has arisen 
over the past decade, particularly with respect to formation during tidal breathing, resulting in 
two major schools of thought. The first states that droplet generation occurs in the upper airways 
due to shedding (arising from instabilities) from surface wave-crests formed in the ALF as the 
result of surface-shearing by air. This mechanism is similar to that involved in cough-generated 
droplets, but occurs at much lower air-flow velocities. Kelvin-Helmholtz instabilities arising 
from core-annular flow were studied experimentally by I. Kataoka in 198226, and droplet 
formation was shown to be theoretically possible for a complete ALF model by J. Moriarty and 
J. Grotberg in 199918. The second mechanism proposed involves droplet shedding from ruptured 
films which arise from the reopening of collapsed bronchioles in the lower airways. The basic 
mechanism of film rupture producing droplets was first reported by Blanchard in 1963 with 
respect to bubbles in sea water27. Small-airway collapse in healthy subjects was established in 
the 1970s (L. Engel et al. demonstrated the phenomenon in 197528), but the link to film-rupture 
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and droplet generation was not suggested until 2009, when it was proposed by G. Johnson and L. 
Morawska19.  
The exact origin of bioaerosols remains an active area of investigation. The pulmonary 
environment and structure, including the properties of the ALF, form the starting point for any 
inquiry. Both mechanisms discussed above will be examined in greater detail, along with an 
analysis of the major forces acting on the droplets after they are formed. 
Airway lining fluid and mucins: 
The basic structure of the ALF is biphasic (Figure 2.1)2, consisting of a viscoelastic (gel) 
upper layer and a serous (sol) sub-layer which act to protect the underlying epithelial cell layer 
(including goblet cells where mucins are formed). The overall thickness ranges from 5 to 100 
microns – the exact thickness varies with health, hydration and location within the lungs3, 
although the sol layer remains relatively invariable at 3 to 5 microns. The primary constituents of 
the ALF are water, proteins (surfactants and mucins) and salt-ions (sodium, potassium, calcium, 
magnesium, etc.). There is also a mixture of lipids, cells (macrophages) and other cellular matter, 
as well as environmental contaminants present (which are typically lodged within the mucus 
upper layer).  
 
Figure 2.1: Basic schematic structure of the ALF coating the epithelial cell lining4 
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ALF is one of the lung’s primary defense mechanisms3, acting as a protective layer 
designed to trap or slow contaminants/pathogens and prevent access to the epithelial layer of the 
lungs, as well as maintain cellular hydration. These trapped contaminants are transported along 
with the ALF via the “mucociliary escalator”5, which involves hair-like cilia extending from the 
epithelial layer through the sol sub-layer and moving in a two-stroke pattern (see Figure 2.2) in 
coordination with surrounding cilia. This process drives the ALF and any trapped material in a 
cephalic direction (towards the head), clearing the pulmonary system and exiting into the throat, 
where it can be swallowed and ultimately digested5. 
 
Figure 2.2: Ciliary two-stroke pattern – recovery stroke in limp state (1-9) followed by an effective stroke6 
The hydration level of the ALF, which directly influences the thickness as well as other 
material properties, is primarily regulated by ion concentrations. Cellular ion channels sensitized 
to concentration trigger the secretion or absorption of aqueous fluid, which is thought to be 
released from serous and clara cells and absorbed by brush cells7. The basic constituents and 
their typical concentrations in healthy ALF are shown in Table 2.1 (data was taken from 
Junqueira’s Basic Histology: Text and Atlas8). 
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Table 2.1: Mucus constituents and concentrations 
 
Mucus forms the upper layer of the ALF. Mucus is a mixture of water and mucin 
glycoproteins (as well as lipids, proteoglycans and salts/minerals)8. Glycoproteins are extremely 
large (molecular mass >1MDa) polymer-like molecules (see Figure 2.3). In human pulmonary 
mucus, the primary mucins expressed are MUC5b and MUC5ac9. The central backbone of the 
mucin monomer is composed of several cysteine rich domains and repeating regions of heavy 
glycosylation (O- and N-linked oligosaccharides). These regions are negatively charged with 
sialic acids and sulfate groups. Disulfide rich domains are found at the terminal ends of the 
monomer, which bundle together to stabilize the un-glycosylated regions of the protein, and 
which can crosslink with other monomers (end-to-end) to form a larger mucus network10.  
 
 
Figure 2.3: Mucin monomer structure11 
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The physical properties of the ALF are specifically adapted to achieve the protective 
coating which is its primary purpose. The viscoelastic nature of mucus provides an elastic and 
physical diffusion barrier to particle contaminants from the environment, while retaining a 
sufficiently viscous nature to allow transport and clearance, as well as maintaining a complete 
covering of the epithelial layer10 (viscoelasticity will be discussed in greater detail within 
Chapter 4). In addition, pulmonary surfactant proteins, combined with lipids, reduce the work of 
breathing by preventing complete collapse and easier expansion of the alveolar termini of the 
pulmonary system. The surface tension is lowest in the alveoli, increasing throughout the lungs 
and towards the trachea13. Reported values for ALF physical properties vary widely as a result of 
methodology and conditions – ranges are listed in Table 2.2. 
Table 2.2: Physical properties of the ALF 
 
The Pulmonary System: 
The pulmonary system’s purpose is to transport oxygen into the bloodstream while 
removing carbon dioxide. It is typically divided into two regions: the conducting portion, which 
is further separated into the upper airways (naso-pharynx, trachea and bronchi) and the lower 
airways (bronchioles and terminal bronchioles); and the respiratory portion, which includes the 
Property Value
Viscoelasticity
     - Complex Modulus 5-50 Pa
     - Loss Tangent 0.2-0.4
Surface Tension
     - Lower Airway 1-30 mN/m
     - Upper Airway 30-60 mN/m
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Table 2.3 contains the average diameters and air velocities for different parts of the lungs. 
The airflow velocities for each subsequent generation are larger than half the value of the 
preceding generation due to the accompanying reduction in airway diameter. The overall result is 
a system which maximizes airflow while minimizing airflow resistance. This, in turn, reduces the 
amount of energy, or “work”, required for breathing. Computation fluid dynamics (CFD) studies 
on tidal breathing within the lungs have confirmed this.16 
Table 2.3: Dimensions and air velocities within the lungs15 
 
 
Bioaerosol formation: Upper airway model 
Bioaerosols form from the ALF, however the exact mechanism and origin within the 
pulmonary system remains controversial. Two basic mechanisms have been proposed, one taking 
place in the upper airways, the other in the lower. The former employs a shear-driven model to 
describe the process, in which surface-shearing of the ALF induces wave formation and 
propagation, potentially leading to instabilities and shedding of droplets18 (see Figure 2.6). This 
process may occur whenever air is flowing across the ALF, although the likelihood of forming 
instabilities varies with surface tension, viscoelasticity and the applied shear force (resulting 
Diameter Length Typical Air
Part Number (mm) (mm) Velocity (m/s)
Nasal Airways 5-9 9
Mouth 1 20 70 3.2
Pharynx 1 30 30 1.4
Trachea 1 18 120 4.4
Two Main Bronchi 2 13 37 3.7
Lobar Bronchi 5 8 28 4
Segmental Bronchi 18 5 60 2.9
Bronchioles 504 2 20 0.6
Secondary Bronchioles 3024 1 15 0.4
Terminal Bronchioles 12100 0.7 5 0.2
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from the air velocity at the interface). Hence, coughing and sneezing, in which much higher air 
velocities occur, are more likely to produce droplets (and in greater numbers) compared to tidal 
breathing. 
 
Figure 2.6: Droplet generation through shearing-induced wave formation 
 
Furthermore, turbulence, characterized by chaotic and rapid variation in air flow patterns, 
can increase wave formation and drive the growth of instabilities. Reynolds Number (Re) is a 
 dimensionless parameter used to describe flow conditions. It is a ratio of the inertial to viscous 
forces acting on the fluid (equa
fluid flows with Re greater than 4000, however transitory turbulence is observed for Re as low as 
2000.
2100. This is near the lower threshold of the transitory flow regime, indicating both laminar and 
turbulent flows are possible. For cough air flow, which involves much higher velocities, Re is 
greater than 7000, so fully developed turbulent flow is
readily formed during coughing compared to tidal breathing. In the lower airways, air flow 
velocities are significantly smaller than they are in the upper airways, and the Reynolds Number 
is of order unity or less,
due to describing cough and sneeze actions (which are expiratory); however, this may not be the 
case for tidal air flows. Experimental 
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were found along the inner wall just past the first and second bifurcation for tidal air flow. 
Coughing, on the other hand, is an expiratory process, with peak air flow rates as high as 12 
L/sec, and during this process, interfacial shearing peaked within the trachea, as it is coupled to 
fully developed turbulent air flow. CFD models of the airways during tidal air flow (performed 
by A. Green in 200317 and Y. Wang et al. in 200933) yielded similar results, and indicate that 
maximal surface shearing may occur during inhalation. These studies suggest that bioaerosol 
formation for tidal air flow may occur proximal to the first bifurcations and be an inhalation-
stage process. If this is the case, then the bifurcation angle is expected to influence droplet 
formation. Furthermore, as an inhalation-stage process, there are ramifications in terms of auto-
infection (the process of transmitting an infection deeper into the host’s pulmonary system). This 
will be an important topic in the upcoming discussion of the lower airway model. 
The experiments on air-shearing of mayonnaise in a rectangular channel performed by 
Basser et al. in 198934 serve as a guide to the relevance of physical properties on the formation of 
wave-instabilities. When mayonnaise – which is a stiff, non-Newtonian fluid – was placed on 
polyethylene, an oily sub-layer formed between the two. The critical air speed required to induce 
instabilities was reduced by half when the sub-layer was present, indicating the significance of 
having both viscous and elastic elements present. This importance was confirmed in the 
computational work performed by Moriarty and Grotberg,18 in which an elastic solid upper layer 
was modeled with a Newtonian sub-layer beneath. Hence, the viscoelastic properties of the ALF 
are expected to be extremely relevant to bioaerosol formation. 
Basser et al. excluded surface tension in their analysis, concluding that their system was 
analogous to wind-water waves in which gravity would dominate any surface tension effects. 
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This analogy does not translate well, as it assumes a deep fluid (in which the ratio of relevant 
wavelengths to depth is very small), whereas in the case of the ALF, the wavelengths must at 
least equal the size (diameter) of the droplets produced (less than 10 microns for bioaerosols), 
compared to a depth between 10-70 microns. This suggests the potential for surface tension 
effects to be relevant, and indeed, Moriarty and Grotberg found that adding a surface tension 
term to their model did significantly alter the results (compared to excluding it). However, once 
accounted for, reasonable changes in the value of the surface tension (from a physiological 
viewpoint) did not continue to significantly alter the outcome, particularly compared to changes 
resulting from the addition of a viscous sub-layer. Hence, changes in the surface tension in the 
upper airways are not expected to play a major role in bioaerosol formation. 
Bioaerosol formation: Lower airway model 
The second mechanism for bioaerosol generation, proposed by Johnson and Morawska, 
occurs in the lower airways, and involves droplets shedding from ruptured films (which form 
through the re-opening of collapsed bronchioles during tidal breathing19). The basic process 
occurs in four stages and is shown in Figure 2.7. In stage one the bronchiole has collapsed at the 
end of the previous expiratory phase. In stage two, inhalation has started and the bronchiole 
begins to open. ALF forms a bridge stretched across the bronchiole. In stage three, the 
bronchiole has completely opened, producing a bubble/film of ALF across the interior which 
subsequently breaks, generating droplets that are immediately entrained in the air stream. In 
stage four, the expiratory phase begins, the droplets are expelled, and the bronchiole begins to 
collapse again. The process is surface-tension dominated20 – determining the capillary number 
(Ca, equation II), which is a dimensionless ratio of viscous forces to surface tension forces, 
yields a value of 0.2 (the zero-shear viscosity of mucus was used as an estimation of fluid 
 viscosity). Surfactant proteins in the ALF reduce surface tension (which is necessary to prevent 
alveolar collapse) 
bronchioles open. The number of droplets produced is a
bronchioles and the frequency of their collapse. Some estimates of bronchiole collapse indicate 
that on average less than 10% of total bronchioles are prone to collapse
amounts are currently unknown.
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Support for this model is largely empirical, with several studies examining either 
expelled breath condensate or droplet number as a function of various breathing patterns. 
Johnson and Morawska, for their 2009 study, used an aerodynamic particle sizer to determine the 
droplet concentration and size expelled from 13 healthy volunteers. The subjects were directed to 
perform several different breathing maneuvers and the resulting droplet data was compared. 
They reported a decrease in droplet concentration (compared to normal breathing) when the 
subjects inhaled normally and then held their breath before exhaling, with the decrease tracking 
with the length of time the subjects held their breath. This suggests droplet formation occurs 
during inhalation, and that droplet settling occurs while breath is held. Furthermore, rapid tidal 
breathing generated more droplets only when inhalation speed was increased. This was taken as 
further evidence that bioaerosol formation during tidal breathing must be an inhalation process, 
and that the mechanism must be film-rupture; however this assumed that the shear-driven 
mechanism in the upper airway was an exhalation-only process (for tidal breathing). While true 
for coughing or sneezing, this is not likely to be the case for tidal air flows, as discussed 
previously. Thus, both mechanisms remain theoretically possible, and more evidence is needed 
to discard one or the other. 
Droplet transport: 
Droplets, no matter where they form in the lungs, will vary in size and their diameters 
will range from hundreds of nanometers to tens of microns. These droplets are immediately 
subject to a number of forces and processes, including transport and gravitational settling. 
Droplet evaporation is not expected to occur within the pulmonary system because it is a moist, 
humid environment (relative humidity approaching 100%). Outside the lungs, evaporation can 
occur and will depend on the specific environmental conditions. As evaporation occurs, droplet 
 diameter decreases, so that larger droplets can shrink to become aerosols. Critical particle 
diameter
to salt content. In terms of transportation, the two most likely methods are diffusion and 
advection (by the air stream). The Péclet number (Pe) is a dimensionless ra
advection (due to bulk fluid flow) to the rate of diffusion (equation III). The larger the value for 
Pe, the more dominant advection is compared to diffusion, and vice versa for values smaller than 
one. A simple order of magnitude analys
estimate of Pe as follows:
Where: 
 
Diffusivity can be calculated as follows:
 
 
Where:
 
 
 
 
 can be reached and will depend on the composition of the droplets, especially in regards 
 
 
 
 
 
 l = Transport length scale
U = Mean air velocity
D = Diffusivity
 k
T = Temperat
µ
d = Droplet diameter
b
 
 
= Viscosity of the bulk media
 
= Boltzmann’s Constant
ure
 
 
is of droplets within the pulmonary system leads to an 
 
 
25
 
 
 
 
 
 
 
(
(
III
IV
)
)
 
 
tio of the rate of 
26 
 
Diffusivity is inversely proportional to droplet size (larger droplets result in greater 
surface drag forces, reducing mobility), and will remain constant throughout the pulmonary 
system (for a given droplet size); therefore Pe should be proportional to droplet size. The length 
scales of interest are on the order of millimeters to centimeters (based on the diameter of the 
airways and the total length of the pulmonary system). The lowest mean air velocity occurs in 
the terminal airway generations – because Pe varies linearly with velocity, it will be minimized 
when velocity is at a minimum (for fixed diffusivity and length scale). Pe was calculated for a 
range of droplet sizes and length scales: the results are shown in Table 2.4. Advection is 
dominant for all conditions throughout the pulmonary system, which indicates that respiratory air 
flow rates are extremely relevant to droplet transport. 
Table 2.4: Pe for a range of droplet sizes 
 
 
Similarly, the gravitational settling rate can be determined as a function of droplet size. 
Figure 2.8 shows the forces acting on a spherical droplet in stagnant air. Using Stoke’s law to 
determine the drag force acting on the droplet as a function of settling velocity (equation V), and 
equating that to the gravitational force acting on the particle as a function of droplet diameter 
(equation VI) the settling velocity can be determined as a function of droplet diameter (equation 
VII). Calculating the settling velocity for a range of droplet sizes (shown in Figure 2.9) indicates 
settling velocities become negligibly small for droplets with diameters less than 10 micron. 
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Figure 2.8: Schematic of forces acting on settling droplet
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Figure 2.9: Settling velocity as a function of droplet diameter 
 
Once formed, larger droplets (> 10 microns) will settle back to the ALF quickly, whereas 
smaller droplets will remain entrained within the air stream. In order for transmission to occur, 
however, the droplets must first escape the lungs. This occurs during the expiratory phase, which 
typically lasts from one to three seconds, so the droplets must be transported from their point of 
origin to the nasal airways or mouth and out to the environment within that period of time. A 
rough estimate of escape time can be determined from the length the droplets must travel through 
each airway generation and the mean air velocity within that generation. The total length droplets 
formed in the upper airways must travel to escape is between 0.22 meters and 0.29 meters. 
Traveling at the mean air velocity for each airway generation, they would require less than 0.1 
seconds to traverse the total distance. Droplets formed in the lower airways must travel an 
additional 0.02 – 0.1 meters (for a total distance between 0.24 meters and 0.39 meters). The time 
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required for these droplets to escape is less than 0.6 seconds. Droplets are therefore theoretically 
capable of escaping the pulmonary system (from either point of origin) during the expiratory 
phase of tidal breathing. During a cough or sneeze much higher air velocities are achieved, 
therefore droplets are expected to escape to the environment in even less time compared to tidal 
breathing.  
Conclusion: 
Two primary mechanisms for droplet formation during tidal breathing were discussed: an 
upper airway and a lower airway model. Investigation of published experimental and 
computational data indicated the upper airway model may actually be an inhalation-process. If 
true, droplet formation is likely to be a function of bifurcation angle. Furthermore, published 
research thought to support the lower airway model would actually fit the new upper airway 
model as well, so that neither model can be confirmed or denied, therefore droplets may 
potentially form in either the upper or lower airways. These droplets are composed of ALF along 
with anything residing in or on the ALF, including pathogens. In this way, pathogens captured in 
these droplets are capable of escaping to the surrounding environment. Upon reaching the 
environment, large droplets will settle or evaporate, decreasing their size until they reach a 
critical equilibrium diameter (which is a function of their composition). At these small sizes (a 
few nanometers to a few microns in diameter) the rate at which they settle, due to gravity, is 
virtually insignificant. Instead, they will remain airborne – transported along air currents where 
they may eventually be inhaled by other individuals, and result in an infection. 
30 
 
References: 
1. Wathes, C. M.; Cox, C. B. (1995). Bioaerosols handbook.  
2. Williams, R.; Rankin, N; Smith, T; Galler, D; Seakins, P (1996) Crit Care Med 24: 1920-1929 
3. Knowles, M. R.; Boucher, R. C. (2002) J Clin Invest. 109(5): 571–577 
4. http://www.lungusa.org/asthmasteroids 
5. Mescher, A. L. (2010) Junqueira’s Basic Histology: Text and Atlas, 12e, Ch. 17 
6. Delmotte, P.; Sanderson, M. J. (2006) Am. J. Respir. Cell Mol. Biol. 10: 1165 
7. Jeffery, P. K.; Reid, L. M. (1977). The respiratory mucus membrane. Respiratory defense mechanisms. 
Part I: 193–245. 
8. Takishima, T.; Shimura, S. (1994) Airway Secretion: Physiological bases for the control of mucous 
hypersecretion, Ch. 6: 224-225 
9. Takishima, T.; Shimura, S. (1994) Airway Secretion: Physiological bases for the control of mucous 
hypersecretion, Ch. 2 
10. Lai, S. K.; Wang, Y.; Wirtz, D.; Hanes, J. (2009) Advanced Drug Delivery Reviews 61(2): 86-100 
11. Ogra, P. L.; Mestecky, J.; Lamm, M. E.; Strober, W.; Bienenstock, J.; McGhee, J. R. (1999) Mucosal 
Immunology: 43-64 
12. Rogers, D. F.; Lethem, M. I. (1997) Airway Mucus: Basic Mechanisms and Clinical Perspectives, Ch. 6: 
119-122 
13. Notter, R. H. (2000) Lung Surfactants, Ch. 6 
14. Thurlbeck, W. M.; Churg, A. M. (1995) Pathology of the lung, 2e, Ch. 3: 90-94 
15. Zeng, X. M.; Martin, G.; Marriott, C. (2001) Particulate Interactions in Dry Powder Formulations of 
Inhalation 
16. Mihaescu, M.; Murugappan, S.; Gutmark, E.; Donnelly, L. F.; Khosla, S.; Kalra, M. (2008) Ann Otol 
Rhinol Laryngol 117(4): 303-309 
17. Green, A. S. (2004) Journal of Biomechanics 37(5): 661-667 
18. Moriarty, J. A.; Grotberg, J. B. (1999) J. Fluid Mech. 387: 1-22 
19. Johnson, G.; Morawska, L. (2009) J Aerosol Med Pulm Drug Deliv. 22:1-9. 
20. Hazel, A. L.; Heil, M. (2005) Proc R. Soc. 461: 1847-1868 
21. Macklem, P. T.; Proctor, D. F.; Hogg, J. C. (1970) Respir Phsysiol.8:191–203 
22. Israelachvili, J. (1991) Intermolecular and Surface Forces 
23. Johnson GR and Morawska L: The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug 
Deliv. 2009;22:1-9. 
24. Gebhart, J.; Anselm, J.; Heyder, J.; Stahlhofen, W. (1988) J. Aerosol Med. 1: 196-197 
25. Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Chao CYH, Li Y, and 
Katoshevski D: Size distribution and sites of origin of droplets expelled from the human respiratory tract 
during expiratory activities. J Aerosol Sci. 2009;40:256-269 
26. Kataoka, I.; Ishii, M.; Mishima, K. (1982) J. Fluids Eng. 105: 230-238 
27. Blanchard, D. (1963) Progr. Oceanogr. 1: 73-202 
28. Engel, L.; Grassino, A.; Anthonisen, N. (1975) J. Appl. Physiol. 38:1117-1125 
29. Haskin, P.; Goodman, L. (1982) AJR 139: 879-882 
30. Weibel, E. (1963) Morphometry of the human lung 
31. Hinds, W. (1982) Aerosol technology: properties, behavior and measurements of airborne particles 
32. Chowdhary, R.; Singh, V.; Tattersfield, A.; Sharma, S.; Subir, K.; Gupta, A. (1999) Journal of Asthma 
36(5): 419-426 
33. Wang, Y.; Liu, Y.; Sun, X.; Yu, S.; Gao, F. (2009) Acta Mech Sin 25: 737-746 
34. Basser, P.; McMahon, T.; Griffith, P. (1989) J. Biomech. Eng. 111: 288-297 
31 
 
Chapter 3: Bioaerosol generation – in vitro models 
Introduction: 
The first hypothesis of this thesis is: 
Droplet generation during tidal breathing can occur in both the 
upper airways (via surface shear) and lower airways (via film 
rupture) during inhalation, and will vary with bifurcation angle 
in the upper airways. 
 
To address this hypothesis, novel in vitro models were developed which were designed to 
replicate the conditions within the pulmonary system that occur during droplet formation (via the 
two potential mechanisms proposed in the literature). A cough model was developed as well and 
is expected to produce the largest number of droplets (via shearing) due to the much higher air 
velocities present. Experiments were performed with each system to examine droplet production 
in terms of number and size. 
Background: 
In chapter 2, bioaerosol transport through the pulmonary system was shown to be 
technically feasible. Two major mechanisms for droplet generation during tidal breathing were 
identified from the literature: films or plugs of ALF rupturing in the lower airways (Johnson and 
Morawska, 200918); and surface shearing of ALF in the upper airways (Moriarty and Grotberg, 
199917). While the role of surface shearing in droplets generated via coughing or sneezing is 
widely accepted, for tidal breathing air flow rates recent studies18-20 of exhaled droplets as a 
function of breathing pattern have reported circumstantial evidence favoring droplet formation as 
an inhalation process. This was taken to mean that the lower airway is the more probable source 
of exhaled droplets; however, evidence was presented in chapter 2 suggesting that wall shear 
stress in the upper airways may peak during inhalation subsequent to bifurcations in the first few 
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generations of the airways, indicating the possibility that the shear-driven mechanism for droplet 
generation may also be an inhalation process (and therefore in agreement with the expelled 
droplet data). If this is the case, then the bifurcation angle is expected to influence droplet 
formation in the upper airway model (due to shifting the peak air velocity closer to the inner 
wall, thereby increasing wall shear stress), and forms the basis for the first hypothesis of this 
thesis. 
Optical Particle Counting Systems: 
 To test the mechanisms for bioaerosol generation discussed in chapter 2, the first 
requirement is a means to determine when droplets are present and in what numbers (as well as 
both their size and size distribution). As discussed previously, the presence of small droplets was 
expected even in the 1940s (Duguid21) but thought to be insignificant, mostly due to the inability 
to observe them. This persisted until the 1990s, after the development of optical particle counters 
(OPCs), which were employed by Papineni and Rosenthal22 to measure expelled droplets. They 
found that the number of small droplets vastly exceeded the number of larger droplets and paved 
the way for a deeper understanding of airborne transmission.  
OPCs come in many shapes and sizes, but the basic mechanism involves measuring laser 
light that has been blocked or scattered by particles passing through the beam1. Refraction and 
diffraction are used to measure the size and number of particles (Figure 3.1). To produce 
accurate, repeatable results, they operate at fixed air flow rates as a closed system. Limitations of 
this method involve the optical particle concentration: if the number of particles per volume of 
air is too great, secondary and tertiary scattering can skew the results (or the intensity may 
become too low); too few particles per volume and insufficient scattering may occur. 
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Figure 3.1: Optical particle detector array2 
  
Many commercially available OPCs used for medical and device research operate at flow 
rates equivalent to peak respiratory rates (such as 1 CFM or 28.3 sLPM). When activated, they 
measure continuously in real-time (sampling times are typically in the 1-3 millisecond 
range).Vacuum pumps are used to maintain air flow at the specified flow rate (and are often 
controlled by software which constantly monitors and adjusts for pressure drops which may 
occur upstream during sampling). These OPCs work well provided they can sample from 
continuously supplied air. As a consequence, they are well-suited for use in systems operating at 
tidal breathing flow rates, but require a more sophisticated setup to work with cough-air systems 
(in which air flow rate varies rapidly and achieves a peak value many times that of tidal 
breathing). To that end, the Exhalair bioaerosol measurement system (pictured in Figure 3.2) was 
created by Pulmatrix, Inc (Lexington, MA). The system uses an Airnet optical particle counter 
(from Particle Measuring Systems, Boulder, CO) coupled to a vacuum pump along with a flow 
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meter and is specifically designed to measure droplets in exhaled tidal- and cough-air while 
simultaneously measuring the air flow rate.  
 
 
Figure 3.2: Exhalair system for measuring droplets in exhaled air (Pulmatrix, Inc.) 
 
Exhaled air is sampled at 28.3 sLPM – if supply air flow rate is greater than the sampling 
rate, excess air is diverted through one-way valves and exhausted through an ultra-low 
penetration air (ULPA) filter (designed to remove greater than 99% of particles greater than 120 
nm in size); if less, the sample air is mixed with ULPA filtered, “clean” air at a known ratio. This 
is advantageous in that it enables accurate droplet measurement for a variety of breathing 
patterns (i.e. tidal breathing at varying rates/volumes, cough-air flows, etc.), however it does 
require the assumption that droplets within the exhaled air are well-mixed, so that sampling a 
portion of said air remains an accurate assessment of overall droplet number. 
Lower Airway Model Development: 
 As described in Chapter 2, the lower airway mechanism of droplet generation involves 
the reopening of collapsed bronchioles, producing a thin film that subsequently breaks into fine 
particles. The droplets are created only during the re-opening stage (as the bronchiole expands), 
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therefore mimicking this step is the minimum requirement of a bench-top system. This was 
accomplished utilizing conical tubes with a maximum diameter equal to that of the fully dilated 
bronchioles and a minimum diameter selected such that a liquid meniscus or film can be created 
by careful sample loading. The minimum diameter was also used as an orifice to control the air 
flow rate through each tube. Figure 3.3 is a schematic diagram of this system: multiple tubes are 
used to prevent the need for additional clean air when measuring with the OPC (the system was 
designed to operate at 28.3 sLPM), which would dilute the sample air stream. A total of 96 tubes 
were used in a parallel flow configuration, to maintain an equal pressure drop across each tube. 
 
 
Figure 3.3: Schematic diagram of lower airway droplet system 
 
 One-way valves were employed at the entrance and exit of the otherwise closed system 
containing the simulated bronchiole tubes to prevent air flow in the reverse direction. The tubes 
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were spaced about three tube-lengths (60 mm) from the entrance and exit, to reduce center-to-
edge variations in pressure drop and air flow. The tubes are the only passage between the upper 
and lower halves of the chamber, which were otherwise completely sealed from each other. 
Sample loading was accomplished via pipette, with care taken to ensure a film/plug was formed 
in each tube prior to starting the experiment. Capillary forces were sufficient to prevent the 
sample from draining (by gravity) from the lower end of each tube.  
 During operation, a vacuum pump (from the OPC) creates a pressure drop across the 
entire system to achieve an overall air flow rate of 28.3 sLPM. Air is drawn into the lower 
chamber through an ULPA filtration system to prevent contamination from the environment, 
then passes through the tubes and ultimately into the OPC. Each tube experiences an equivalent 
pressure drop due to their parallel configuration and spacing from the container walls. Along 
with air, the sample film is driven upwards through the tube. Due to the conical shape of the 
tube, the film expands as it moves, mimicking the film expansion that occurs within the 
expanding bronchioles in vivo, until it reaches a critical thickness/area and breaks, shedding 
droplets which are entrained within the air stream and drawn out to the OPC. 
Upper Airway Model Development: 
 The upper airway model describes a shear-driven mechanism for droplet generation. 
Shear stresses along the ALF are proportional to the velocity of the air passing over it, so shear 
stress is expected to be highest in the upper airways and trachea, where the velocity peaks. Early 
in vitro systems to study cough-generated shear forces on the ALF were created by King et al. in 
the 1980s with the initial motivation to study how shearing from air flow was involved in mucus 
transport and clearance3,4. These studies used a simulated cough system consisting of a 
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rectangular channel in which mucus or mucus simulants were placed as a thin layer coating the 
bottom of the channel. The dimensions of the channel were such that the cross-sectional area (but 
not shape) was similar to that of the human trachea. Air was forced through the channel by 
generating a high pressure bolus of air upstream to produce flow rates matching those in the 
trachea of humans during coughing. A schematic of this system is shown in Figure 3.4 
 
Figure 3.4: Schematic of King’s simulated cough system – (1) Air tank;(2) 
Solenoid valve; (3) Laminar flow element;(4) Pneuomotachograph;(5) Trough 
(model trachea);(6) Differential pressure transducer7 
 
This model was adapted for use in studying droplet generation from cough shearing by 
Edwards and Watanabe et al.6,7 by adding a collection vessel on the outlet and sampling with an 
OPC. An ULPA filter was also added prior to the trough to prevent particle contamination from 
upstream components. The collection vessel was basically a chamber-and-piston setup with 
variable volume. This acted to contain the cough-air exhaled from the trough, but meant that the 
air remained stagnant for several minutes while the OPC sampled the entire cough volume at a 
fixed volumetric flow rate (28.3 sLPM). Droplet deposition along the walls of the container over 
the duration of time spent sampling the exhaled air could potentially result in lower 
measurements of total droplets produced. Furthermore, the square cross-section of the trough and 
the use of laminar flow elements altered the air-flow profile experienced by the mucus, and could 
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significantly influence droplet production, potentially resulting in a poor “fit” to the real 
pulmonary system. To compensate for these factors, the system was overhauled to create a new 
and improved simulated cough system. 
Simulated Cough System: 
The collection vessel was eliminated in the new simulated cough system – it was replaced 
by real-time sampling via an Exhalair. The air tank at the inlet of the system was replaced by a 
Breathing Simulator (MH Custom Design and Mfg., Midvale, UT), which is capable of 
generating specific, repeatable air-flow profiles. The simulated cough profile fed to the Breathing 
Simulator was generated from a mathematical model developed by Chen et al.8 to fit data 
collected from volunteers. The final flow profile used is shown in Figure 3.5, with a peak flow 
rate of 6 liters per second (360 sLPM), a total duration of just under 0.4 seconds and a total 
volume of approximately 1 liter. Cough air exiting the trough was sampled by the Exhalair 
system at 28.3 sLPM, with excess air exhausting to an ULPA filter.  
 
 
Figure 3.5: Cough-air flow profile 
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Figure 3.6: (a) Modified cough-trough (b) Cross-sectional schematic of modified cough-trough 
 
The rectangular-channel trough was replaced with a nearly-cylindrical geometry (with a 
flattened section, see Figure 3.6). The primarily cylindrical geometry was used to reduce artifacts 
in air flow caused by the corners of the rectangular channel (compared to within the pulmonary 
system). The diameter of the cylindrical portion is equal to that of the trachea during a cough, 
which is smaller than for tidal breathing because the trachea constricts immediately prior to 
coughing (to further increase air velocities and thereby increase shear forces and clearance9). The 
flattened portion was incorporated to maintain a more uniform height of the mucus sample, 
which is spread over a fixed area at fixed volume. The exposed sample area is approximately 10 
cm2 or about 20% of the surface area of the human trachea. The final system is shown in Figure 
3.7. 
 
Figure 3.7: Simulated Cough System - (1) Breathing simulator; (2) ULPA 
filter; (3) Modified trough; (4) Exhalair; (5) Exhaust ULPA filter 
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Tidal breathing system: 
The simulated cough system was also used to explore droplet formation during tidal 
breathing, although the following adjustments were required: the diameter of the model trachea 
was increased to 1.8 cm and the air flow profile fed to the breathing simulator was changed to a 
simple step-function with a maximum air flow rate of 28.3 sLPM (to simulate normal 
exhalation). However, in order to investigate whether the bifurcation angle influences droplet 
generation during inhalation, a separate system was developed. A physical model was created 
with physiologically appropriate dimensions and adjustable bifurcation angle, as shown in Figure 
3.8. One arm of the bifurcation contained the sample on a horizontal plane located where surface 
shear forces were expected to reach a maximum, as indicated by CFD studies of the upper 
airways performed by Green (2004)10 and Wang et al. (2009)23. Both arms were connected to an 
OPC with vacuum-pump controlled air flow rate. 
 
 
Figure 3.8: Tidal breathing system with adjustable bifurcation angle 
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Sample Mucus: 
Healthy ALF is only present in small volumes and is extremely difficult to collect. A 
frequently used substitute is simulated epithelial lining fluid (sELF). sELF is a prepared solution 
of commercially available pig gastric mucin (1.5%w/w PGM, Sigma) and 
dipalmitoylphosphatidylcholine (1%w/w DPPC, Sigma) in Hank’s balanced salt solution (HBSS, 
Sigma). DPPC is the lipid found in lung surfactant which is primarily responsible for reducing 
surface tension11. Reconstituting DPPC in solution was accomplished according to the procedure 
outlined by Pinazo et al.12 The physical properties of sELF are shown in Table 3.1 – viscoelastic 
parameters were measured with an AR-G2 rheometer (TA Instruments, New Castle, DE); surface 
tension was measured with a SITA t60 bubble-pressure tensiometer (SITA Messtechnik, 
Dresden, Germany). All samples were loaded into the system in a particle free environment to 
avoid background contamination. 
Table 3.1: sELF physical properties 
 
 
 
 
Property Value
Viscoelasticity
     - Complex Modulus 5 Pa
     - Loss Tangent 0.38
Surface Tension 31 mN/m
       ( 0.2 Hz)
pH 7
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Results: 
Results for each system are presented as droplet concentration (the total number of 
droplets per liter of sample air – and per tube/bronchiole for the lower airway model) and are 
shown in Figure 3.9. Coughing produced the largest concentration of droplets (122 per liter of air 
+/- 20), as expected. Reported measurements of droplets produced by cough from healthy 
volunteers vary, ranging from several hundred to a few thousand per liter13,14; however this 
includes contributions from the mouth and pharynx. Furthermore, the exposed sample interfacial 
area in the simulated cough system is approximately 20% of that in the human trachea. On a per 
area basis, the simulated cough system produced 12.2 droplets per liter per square centimeter, 
compared to approximately 15.4 per liter per square centimeter for healthy human volunteers,13 
which is reasonably good agreement.   
 
 
Figure 3.9: Cumulative droplets per liter of air produced by each system 
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The lower airway system produced an average of 11 +/- 3 droplets per liter of air per 
tube. Reported droplet numbers produced via tidal breathing by healthy volunteers varies widely 
within the literature, with concentrations ranging between 1 and several thousand, even between 
different individuals.6,13,14 This makes a direct comparison difficult, however Edwards et al. 
(PNAS, 2004)6 found that between 20% and 30% of the subjects in their study if expelled 
droplets produced significantly more droplets than the rest of the study group. They defined this 
group as “super-producers” (characterized as producing greater than 500 droplets per liter air). 
Using this cut-off as a guide, a minimum of 46 bronchioles simultaneously collapsing and 
expanding would be needed to reach the threshold of super-producing. This represents 
approximately 10% of the total number of bronchioles in healthy adults. 
Adapting the simulated cough system for tidal breathing resulted in zero droplets. This 
was consistent with the results from the bifurcation system as an approximation for a zero degree 
bifurcation angle. The bifurcation system results are shown in Figure 3.10 (adjusted to a per 
exposed surface area basis) – droplet concentrations decreased as bifurcation angle decreased 
and vice versa. For adults, the average bifurcation angle of the bronchi (as measured by 
radiographs) is 30 +/- 6 degrees.15 Bioaerosol concentrations increased significantly for 
bifurcation angles between 35 and 40 degrees, and approached the threshold for super-producing 
(~18 droplets per liter per square centimeter) around 38 degrees. This suggests that critical air 
velocity at the ALF interface is achieved for a bifurcation angle between 35 and 40 degrees. 
Based on these results, a small portion of the population, much less than 20%, is expected to fall 
into the super-producer category based on bifurcation angle alone. 
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Figure 3.10: Bifurcation system results: Droplets per liter air per square centimeter exposed ALF 
 
Conclusion: 
 In vitro systems were developed to replicate conditions for bioaerosol formation and 
measure the number of droplets formed according to the mechanisms discussed in chapter 2: a 
lower airway system designed to mimic bronchiole expansion and film rupturing; a shear-driven 
trachea model for both tidal and cough air flow patterns; and a shear-driven model of the first 
bifurcation with variable bifurcation angle. The shear-driven cough model produced the highest 
concentration of droplets, as expected, and was in reasonable agreement with data reported in the 
literature.  
Droplet formation was shown to depend on bifurcation angle for the shear driven model 
at tidal air flow rates, with no droplets measured from the trachea model. This supports the first 
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hypothesis, which states that bioaerosol generation in the upper airways for tidal airflows occurs 
during inhalation. This is actually consistent with the expelled droplet data produced by Johnson 
and Morawska (2009)18 and Almstrand et al. (2010)19 which indicated that droplets were more 
likely to be produced during inhalation (they concluded this meant the lower airway model was 
therefore the real mechanism however these findings suggest that is not the only possibility). 
This has ramifications for auto-infection as well: bioaerosol formation occurring in the upper 
airways during inhalation can yield droplet deposition deeper in the lungs (especially for larger 
droplets, greater than 10 microns in diameter). This can potentially move an existing or 
developing infection deeper within the pulmonary system.  
While both tidal air flow systems examined were capable of producing sufficient droplets 
to meet the threshold for super-producing, the conditions under which either case was observed 
is unlikely to occur by itself in enough of the population to adequately explain the results 
reported  by Edwards et al6. For instance, the results from the bifurcation system indicate that the 
angle required to surpass the droplet concentration threshold for super-producing was 45 
degrees, which is greater than two standard deviations above the mean bifurcation angle. 
However, if the results from both the lower airway system and the upper airway system are taken 
together, a number of combined solutions become plausible. Super-producers may have some 
combination of both airway geometry (e.g. large bifurcation angle at the bronchi) and collapsing 
bronchioles which results in their large bioaerosol numbers. Alternatively, it may be that some 
super-producers are due to being outliers in terms of bifurcation angle, while others are due to 
having a large number of collapsing bronchioles. The combined total from all of these 
possibilities may then match the percentage of the population observed in Edwards’ study. 
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Chapter 4: Mucus rheology, response to salt addition, and resultant droplet formation 
Introduction: 
In chapter 3, bench-top systems for droplet generation were created and compared to 
existing literature for validation. As the overall focus remains on bioaerosols and methods to 
prevent their formation, the next step involves investigating the second hypothesis of this thesis, 
which states: 
Mucus viscoelasticity will influence droplet formation by shear 
forces, with increased stiffness yielding fewer droplets in total. 
 
This hypothesis will be explored by examining the physical properties of the airway 
lining fluid (ALF), the role those properties play in droplet formation, and the means of altering 
those properties to reduce or prevent droplet generation. The properties of interest are the surface 
tension at the air-ALF interface and the viscoelasticity of mucus. However, based on the 
theoretical work performed by Moriarty and Grotberg16 as well as the experimental results 
published by Edwards et al.17 and Watanabe et al.18 changes in surface tension, which tends to 
act as a stabilizing force, do not significantly influence droplet formation (for the range of 
physiologically relevant surface tension values, as found in the upper airways). Furthermore, as 
Edwards et al. reported, changes in viscoelasticity appeared to reduce expelled droplet numbers. 
Mucus viscoelasticity is therefore of primary interest. 
Background: 
Mucus is the primary component of ALF, and provides a protective coating which 
maintains hydration and serves as a physical barrier to foreign material. It can be found in the 
pulmonary system, eyes, gastrointestinal tract and other moist, sensitive areas of the body1. It is 
composed primarily of water and mucin macromolecules and is characterized by its viscoelastic 
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response to shear forces, demonstrating thixotropic behavior. This response is a function of its 
composition, and is specifically tuned to optimize the protective properties of mucus. Collection 
of adequate quantities of healthy pulmonary mucus has generally proven a major challenge, as it 
is produced in low volume, and covers the surface area of the pulmonary system. Typically, it 
has been obtained through sputum induction, which involves inhalation of salt-containing 
aerosols which alter its physical properties. Therefore substitutes for healthy pulmonary mucus 
have been investigated, including animal-derived sources and human cell culture models.3 
Comparisons have also been made to disease-state pulmonary mucus (e.g. chronic obstructive 
pulmonary disorder (COPD), cystic fibrosis (CF), etc.).4,5 
Numerous studies have been performed on the viscoelasticity of mucus (healthy when 
possible, as well as diseased state) and mucus substitutes. In particular, Lutz et al. (1973)19, King 
et al. (1977)20, Crowther et al. (1984)2and Lethem et al. (1990)21 contributed to the development 
of methods for measuring mucus viscoelasticity as well as characterizing its properties. Their 
work formed the foundation for investigating the changes in disease-state mucus and mucus 
functionality. For example, Lethem examined the properties of CF mucus and determined how 
the observed changes in viscoelasticity were the result of variations in the glycoprotein network. 
Crowther and Marriott demonstrated the viscoelastic sensitivity to ion concentration of pig 
gastric mucus, in particular cations such as calcium (although they only looked at very small ion 
concentrations).They saw an increase in viscoelasticity in response to calcium exposure2, and 
posited a charge-shielding mechanism to explain it13. This is of particular relevance to the 
current work, as ions present a means of altering mucus viscoelasticity. However, the 
concentration range will be expanded and applied to whichever mucus source is found to be most 
 suitable. Once that is accomplished, bioaerosol formation as a function of mucus viscoelasticity 
can then be measured using the simulated cough machine developed in chapter 3.
Mucus
 
MUC5b and MUC5ac in pulmonary mucus). The fluid properties of mucus arises from the 
interaction of these molecules: non
produce a macroscopic network in constant flux which can also elastically deform under stress, 
storing potential energy in a mechanical “spring
can act as a pseudo
chains are also in motion relative to each other and this motion gives rise to viscous flow. Hence, 
mucus exhibits behaviors similar to both viscous fluids and elastic solids.
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When a shear stress is applied to the mucin network, the mucin chains are stretched, 
creating strain. The mucins may also slide along each other, dis-entangling and flowing in the 
direction of the stress, reducing tension in the system. Over a longer period of time, the inter-
mucin bonds may break (and reform), which further reduces overall strain. If the applied stress is 
removed, the system can relax; however the final state will differ from the pre-stress state 
depending on the relative amounts of elastic deformation and flow, as well as the overall time-
scale. In other words, the applied stress will be correlated with both the strain (as in an elastic 
solid) and the rate of strain (as in a viscous, or Newtonian, fluid). The study of such complex 
fluid flow is called rheology. Rheometers are used to measure the viscoelastic properties of 
materials. Samples are loaded into a particular geometry which is attached to the rheometer: 
there are many types of geometries, including plate/plate, cone and plate, and couette, each of 
which consists of at least two components and which is designed to apply shear force to the 
sample. An example of a cone and plate geometry is shown in Figure 4.2. 
 
 
Figure 4.2: Cone and plate geometry 
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 As in Figure 4.2, sample is loaded between the cone and plate, and care is taken to insure 
that no air bubbles or gaps are present, nor that any excess material is outside the diameter of the 
cone. The cone is rotated with respect to the plate and the applied stress (the torque on the 
spindle attached to the cone over the interfacial area) is measured along with the rotational 
displacement. Strain is calculated as the displacement distance divided by the sample height: one 
advantage of the cone and plate geometry is that the sample is subjected to uniform strain (for a 
fixed displacement angle, the displacement length is a function of radius, and the sample height 
is designed to be a function of radius as well, resulting in uniform strain).  
The rheometer can be operated in two basic modes: a rotational or direct shear mode in 
which the cone is rotated at a set speed or to a set displacement; and an oscillatory mode, in 
which the cone oscillates back and forth with a particular frequency. The former is used to 
generate information about how the sample responds to fixed stress, strain, or shear rate – for 
example, the shear-thinning behavior of mucus is observed with this method – but it may be 
destructive to the sample’s networked structure. The latter is used to ascertain the importance of 
time-scales and measure viscoelastic properties without permanently altering the network 
structure. During an oscillatory experiment, a sinusoidal stress or strain is applied to the sample 
and the resulting strain/stress is measured (an example is shown in Figure 4.3). The phase lag 
between the stress and strain curves is dependent on the sample type: a Newtonian fluid would 
be 90 degrees out of phase, whereas an ideal, elastic solid would be perfectly in-phase. The 
phase lag for complex (non-Newtonian) fluids will fall somewhere between 0 and 90 degrees. 
The viscoelasticity of the sample can then be quantified as a complex number, defined as the 
complex (dynamic) modulus, G* (equation III), with phase angle δ. 
  
 
 
Figure 4.3: Example of sinusoidal applied stress and strain (at frequency 
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pulmonary mucus reported in the literature. For all samples, viscoelasticity was measured with 
an AR-G2 rheometer with cone and plate geometry (TA Instruments, New Castle, DE) and 
results were compared to healthy mucus. Results for all samples are shown in Figures 4.4 
(complex modulus) and 4.5 (loss tangent). 
Table 4.1: Reported values for viscoelasticity of healthy pulmonary mucus13 
 
Mimetics: 
 Various natural and synthetic gums and gels have been explored in the literature, such as 
guar gum, locust bean gum and sodium alginate7. Sodium alginate is a long-chain molecule 
which is cross-linked by calcium to form a gel. The gel properties are dependent on the alginate 
concentration as well as the calcium concentration used to crosslink the sample, although these 
parameters are limited by solubility and the number of available cross-linking sites. The closest 
match to healthy mucus was obtained from a 2% w/w alginate solution cross-linked by 1 mM 
calcium chloride – viscoelastic results are presented in Figures 4.4 and 4.5. 
Property Value
Viscoelasticity
     - Complex Modulus 2-10 Pa
     - Loss Tangent 0.2-0.4
55 
 
 
Figure 4.4: Complex modulus (magnitude) for alternative mucus sources 
 
Figure 4.5: Loss tangent values for alternative mucus samples 
 Figure 4.6
viscoelastic “states” (i.e. matching viscoelastic properties under specific conditions). Their 
response to cha
agents and other compounds will not match the response of mucus to those same changes. 
Animal
 
gastric and cervical mucins extracted from pigs or cows. Similar for humans, pulmonary sources 
are low volume, and therefore rarely considered. Purified bovine submaxillary mucin
(MP Bio, Solon, OH) are commercially available as lyophilized powders, as are porcine gastric 
mucins (PGM) (Sigma Aldrich, St. Lois, MO), although the specific procedures used for 
processing the samples were not released by the manufacturers. Addit
mucus was collected from freshly harvested pig stomachs and purified following procedures 
outlined in reference 8. Results are shown in Figures 4.
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-
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freshly purified PGM was a strong match, but unfortunately the collection process was 
prohibitively time-intensive for the amount of material produced (3-4 weeks were required to 
produce a few hundred milligrams of final product). 
Human sources: 
 Two human-based sources of pulmonary mucus were examined: mucus secreted from 
Calu-3 cells (which are cultured from human airway epithelial cells)9; and sputum obtained from 
patients suffering from chronic obstructive pulmonary disorder (COPD). Calu-3 cell cultures 
produced a few hundred microliters of mucus on a weekly basis, so several cultures were 
harvested concurrently and the secretions pooled over time to produce useable quantities. COPD 
is characterized by excessive production of pulmonary mucus (with volumes exceeding tens of 
milliliters per day from a single individual). Unlike in cystic fibrosis (CF), in which much 
thicker, stiffer mucus is produced, COPD mucus has been found to more closely match healthy 
mucus10. Sputum samples were collected by a third party and provided for research purposes: 10 
patients provided a sputum sample daily for five days. All samples were kept frozen at -80oC 
until needed, at which point individual samples were thawed for testing as needed. Results are 
included in Figures 4.4 and 4.5: Calu-3 secretions were a poor match for healthy mucus; 
however, as expected, COPD sputum was a very strong match. COPD was selected for further 
characterization and experimentation. 
 Large variations in viscoelasticity were observed between COPD sputum samples 
provided by different individuals, specifically in the complex modulus (inter-patient sample data 
is shown in Figure 4.7). The mean value for complex modulus across all samples was 5.3 Pa. 
The relative standard deviation (RSD) was 58.6%. Much less variation was observed in the loss 
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tangent (mean: 0.253; RSD: 17.98%). Variations between samples provided by the same 
individual on different days were observed as well, however they tended to be smaller than the 
range observed across different individuals. Figure 4.8 shows the RSD in the complex modulus 
across samples collected over multiple days for each individual. 
 
 
Figure 4.7: Inter-patient viscoelasticity in COPD sputum  – (a) Magnitude of complex modulus; (b) Loss tangent 
 
Figure 4.8: Intra-patient variation in COPD sputum  – (a) RSD of complex modulus; (b) RSD of Loss tangent 
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 As a result of the observed variation, samples were pre-screened and selected for 
viscoelastic parameters: samples were accepted for further testing provided the mean complex 
modulus was within one standard deviation of the overall sample mean (between 3 and 6 Pa). 
Samples outside this range were considered outliers for the purposes of further experimentation. 
Furthermore, for studies involving the effect of salt exposure, viscoelastic parameters were 
normalized against their baseline (untreated) values to aid in comparing results. 
Bulk additives: 
 In order to explore the effect of cations on mucus viscoelasticity, different salts were 
added in bulk to COPD sputum samples at varying concentrations and the resulting 
viscoelasticity was measured. Four salts were investigated: calcium chloride, magnesium 
chloride, sodium chloride and potassium chloride (all obtained from Sigma Aldrich). Calcium 
and magnesium are divalent cations; sodium and potassium are monovalent cations. Results are 
shown in Figures 4.9 and 4.10: at low cation concentrations, decreases in the loss tangent and 
increases in the complex modulus (compared to baseline values) were observed. The effect was 
greater for the divalent cations compared to the monovalent cations. These changes indicate 
increased gel stiffness arising from increasing elasticity (larger complex modulus, smaller loss 
tangent). However, as the concentration was increased the response was reversed and ultimately 
the overall stiffness decreased, with greater losses in the storage moduli than loss moduli 
(smaller complex modulus, larger loss tangent). Variation in the results was reasonably large, 
typically between 10 and 20% RSD, with a few outliers, but this reflects the baseline variation in 
the sputum samples themselves in addition to any experimental error. 
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Figure 4.9: Normalized complex modulus versus cation concentration 
 
Figure 4.10: Normalized loss tangent versus cation concentration 
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droplet concentration tended to decrease at low cation concentration and then rise significantly as 
cation concentrations were increased. The largest decreases were observed for the divalent 
cations (calcium and magnesium). This appears to match the viscoelastic response to cation 
concentration previously observed.  
 
Figure 4.12: Droplet concentration versus bulk sample cation concentration 
 
Comparing droplet concentration to the normalized complex modulus for each sample 
indicates a strong inverse correlation (correlation coefficient of -0.96) between particle 
generation and viscoelasticity (Figure 4.13), with over 90% (R2 greater than 0.9) of the variance 
in droplet concentration accounted for by the normalized complex modulus. However, as 
previously discussed, the intra-sample variability in both parameters is still quite large. 
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Figure 4.13: Scatterplot of droplet concentration versus normalized complex modulus (n ≥ 3 for all samples) 
 
To determine whether the intra-sample variability would significantly alter the results, the 
data from every individual experiment (rather than the average over multiple replicates) was 
pooled and the droplet concentration versus complex modulus was plotted (Figure 4.14). 
Unsurprisingly, the sample noise can be seen as a direct influence on the variance (R2 of 0.79) as 
well as the overall correlation strength (correlation coefficient of -0.89), which is still strong. The 
same overall trend is still apparent. 
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Figure 4.14: Scatterplot of droplet concentration versus complex modulus for individual experiments 
 
Conclusion: 
 After extensive exploration of available alternatives to healthy human pulmonary mucus, 
COPD sputum was selected as the best viscoelastic substitute. Freshly purified and reconstituted 
PGM was also a reasonable fit; however time and manufacturing constraints limited its 
availability. Inter- and intra-patient variability in the viscoelasticity of the COPD sputum 
samples were examined, along with the bulk addition of various salts: normalization was used to 
determine and compare changes in viscoelasticity.  
Changes in viscoelasticity were observed as a result of salt exposure: the magnitude and 
direction of such changes were dependent on cation concentration as well as cation valency. This 
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response was consistent (at low cation concentration) with the work performed by Crowther and 
Marriott, and is attributed to the same charge-shielding mechanism they proposed. The treated 
and untreated samples were also used in a simulated cough system to measure droplet 
production. Droplet concentration was found to be inversely correlated with the complex 
modulus of the sample. These results confirm the second hypothesis: that altering the 
viscoelasticity of mucus (in this case through addition of cationic agents) would influence shear-
induced bioaerosol generation. 
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Chapter 5: Preventing bioaerosol transport by modifying mucus viscoelasticity 
Introduction: 
In Chapter 4, a correlation between mucus viscoelasticity and droplets generated by 
cough-induced surface-shearing was established and confirmed the second hypothesis. Mucus 
viscoelasticity was modified through cationic exposure. These results were in agreement with 
published work performed by Edwards et al.9, Watanabe et al.10 and Clarke et al.11 and can be 
applied in vitro to determine how modifying mucus viscoelasticity influences the transport of 
pathogens via bioaerosols. Pathogen transport will be established for both bacteria and viruses, 
after which the effect of cationic treatment of infected mucus will be explored in order to test the 
third hypothesis, which states: 
Reducing the number of bioaerosols generated decreases the 
probability of pathogen transport, and therefore the 
transmission of infection. 
 
Calcium was selected as the appropriate cation to modify the viscoelasticity of COPD 
sputum based upon the increased sensitivity observed in the previous chapter. This will be 
investigated using a modified version of the simulated cough system previously developed. 
Background: 
Attempts to collect pathogen from expelled droplets have advanced significantly from the 
large-droplet impaction studies of Duguid12 in the 1940s. Modern methods include impactors, 
which are designed such that the air flow path enters through one end of the device and must 
curve sharply to pass around a large dish or plate (or a series of plates), before exiting out the 
other end. This creates the potential for inertial impaction (onto the plate) of particles within the 
air stream that are too aerodynamically large to follow the air flow path around the dish. Multiple 
68 
 
stages with varying size cut-offs can be used to determine the size distribution. Liquid impingers 
operate in a similar fashion, but particles are collected in liquid, rather than deposited directly 
onto plates. 
Airborne transmission has been successfully demonstrated between animals: in 1962 
Riley et al.13 published a study in which guinea pigs that were exposed to air from a tuberculosis 
ward became infected. Autopsies of the infected guinea pigs revealed that only a single 
infectious droplet was necessary to initiate infection. In 2011, A. Nalca and D. Nichols14 
published results demonstrating bioaerosol transmission of rabbit pox between healthy and 
infected rabbits. Unpublished work by members of Pulmatrix15, Inc. has also shown disease 
transmission by aerosol in cattle and pigs, as well as a reduction in transmission via cationic 
treatment, however no direct measurements of the properties of the animals’ airway mucus was 
possible. Hence the need for an in vitro system to monitor pathogen transmission under 
controlled settings in which the mucus properties can be measured and treatment effects 
analyzed. 
Test system development: 
The simulated cough system presented in chapters 3 and 4 was modified as follows: the 
Exhalair system (for measuring droplet number and size) was replaced by a single-stage viable 
Anderson Cascade Impactor (viable-ACI, Thermo Scientific, Waltham, MA). Viable-ACIs can 
be single- or multi-stage, and are used to characterize the number, aerodynamic size and size 
distribution of airborne, biologically-active particles. The impactor was placed approximately 15 
centimeters downstream from the pseudo-trachea with a trap between them to prevent sample 
material from being pushed into the impactor. A schematic of the complete system is shown in 
 Figure 5.1. An ULPA filter was placed after the impactor to collect any droplets which did not 
deposit and remained airborne.
a petri dish, co
in the impactor. The cough maneuver was then initiated: any droplets formed travel to the 
impactor, where they may contaminate the receptor material within the petri dish. A
the petri dish was removed and the receptor material was either placed directly into an incubator 
(agar plates) or removed and placed over cell cultures (cell media). These were subsequently 
observed for the presence of pathogens.
 
 
 
 
The mucus sample was loaded into the pseudo
Figure 5.1:
Filter; (3) Pseudo
ntaining appropriate receptor material, such as agar gel or cell media, was placed 
 Schematic of experimental transmission system: (1) Breathing Simulator;(2) ULPA 
-trachea; (4) Impactor; (5) 
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Method development: 
 COPD sputum was used for all mucus samples. All calcium-treated mucus samples were 
exposed to a final concentration of 116 mM calcium, which corresponded to the largest increase 
in complex modulus and largest decrease in loss tangent (Figure 5.2). The viscoelasticity of all 
samples (calcium-treated and untreated) was measured prior to each experiment to confirm 
agreement with previous results.  
An unknown bacterium was present in the raw mucus samples. Plating “neat” sputum on 
chocolate agar and incubating at 32oC for 24 hours resulted in the observation of hundreds of 
CFU. Sputum was serially diluted with phosphate buffered saline and plated. CFUs of the 
unknown bacteria were observed down to a dilution of 1:1000. Calcium-treated sputum yielded 
similar results, indicating that there was no direct effect of calcium-treatment (at the selected 
concentration) on bacteria quantity; however treatment with an anti-bacterial Penicillin-
Streptomycin (“pen-strep”) solution was able to eliminate the observed bacteria.  
The presence of native bacteria in the sputum samples prevented direct addition of known 
bacteria for experimental purposes, as all results would be contaminated by the native bacteria. 
However, treatment of the mucus with pen-strep was not a functional solution. An effective dose 
required too large a volume and produced a diluting effect on the mucus samples. It would also 
have required that any subsequently added bacteria be resistant to both penicillin and 
streptomycin.  
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Figure 5.2: Changes in COPD sputum viscoelasticity resulting from calcium treatment 
 
The native bacteria did present an opportunity to test the system for proof-of-concept 
with a simple positive/negative outcome (i.e. bacteria is either present or not present for a given 
mucus sample or condition). Three conditions were tested: no mucus (to check for background 
contamination), untreated mucus (to establish positive bacterial transport) and calcium-treated 
mucus (to determine effectiveness of cationic treatment). Each sample was loaded into the 
pseudo-trachea and spread over a fixed area before initiating the cough. Chocolate agar plates 
were used in the impactor to collect droplets (and enable the growth of any bacteria that reached 
them). The plates were incubated at 32oC for up to 48 hours post-exposure. They were then 
observed for bacterial growth and CFUs were counted by hand. Results are shown in Figure 5.3. 
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Figure 5.3: CFU of native bacteria observed 48 hours after cough exposure 
 
 As expected, when no mucus was used, no bacteria were observed on the agar plates, 
confirming a clean, uncontaminated background. When untreated mucus was tested, a small 
number of CFU were observed (5.2±1.9 CFU), indicating that at least a few bacteria were 
successfully transported via droplets and thereby providing a positive control for the system. 
When the mucus was treated with calcium, fewer CFU were observed (0.2±0.45 CFU) – four out 
of five replicates did not show any CFU at 48 hours. A t-test confirmed that the difference 
observed between the sample groups is statistically significant (p < 0.0024). Hence, the proof-of-
concept for the simulated cough and impactor system was successful; furthermore, cationic 
treatment of mucus (to increase viscoelasticity) was demonstrated to reduce bacterial transport 
via airborne droplets. 
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Viral Transport: 
 Human rhinovirus (HRV) was used to examine viral transport: it was selected due to its 
prevalence as well its robustness. HRVs are considered the primary cause of the common cold, 
and are amongst the most common viral pathogens in humans. They can infect both the upper 
and lower respiratory tract, although they are primarily an upper respiratory tract disease. HRVs 
grow optimally at 31-33oC (which is the typical temperature in the upper airways). They are 
extremely small, with a diameter of approximately 30 nanometers.4 
The first step in an HRV infection begins when the virus attaches to Inter-Cellular 
Adhesion Molecule 1 (ICAM-1), a surface protein found on epithelial cells (Figure 5.4). This 
attachment occurs rapidly after exposure, typically occurring within 15 minutes, and causes a 
conformational change in the virus which triggers the release and transport of viral RNA into the 
cell,5 however, symptoms do not typically appear for another 1 to 4 days after infection. HRV 
remains functionally intact in solution, at room temperature, for over an hour. This is significant, 
as it allows sufficient time for sample preparation and experimentation (as compared to 
influenza, which degrades much more rapidly and would require accelerated experimental 
protocols). 
  
cultures of an HRV
were exposed to HRV at varyi
and subsequently observed for cell death over 96 hours. This resulted in a set of data involving 
the time
e
time of death post
calcium treatment would directly influence HRV activity, HRV was add
of CaCl
was then directly added to HRV
with the equivalent reference standard, ind
of CaCl
xperiments to approximate the amount of virus that cells had been exposed to (using only the 
In order to create a reference standard for cell death following viral exposure, cell 
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 in cell culture media and incubated at room temperature for 15 minutes. The solution 
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-exposure). Results are included in
-
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Results: 
Calcium-treated and untreated sputum samples were spiked with approximately 107 HRV 
(Rhinovirus 16, ATCC, Manassas, VA) virions and gently agitated for 10 minutes to allow for 
complete mixing. No changes were observed in mucus viscoelasticity within 30 minutes of virus 
exposure (which was the length of time needed to prepare the samples, then load and run the 
simulated cough system). Magnesium fortified cell-culture media was placed in petri dishes and 
loaded into the impactor. After cough exposure, the contaminated media was placed on HRV-
sensitized HeLa cell-cultures. The following conditions were tested: untreated sputum without 
virus (“neat”); untreated sputum with virus; and calcium-treated sputum with virus. Exposed 
cells were incubated at 32oC for 96 hours post-exposure, and assessed visually (via microscopy) 
every 24 hours for cell death; results are shown in Table 5.1. 
 
Table 5.1: HeLa cell culture response to cough-contaminated media over 96 hours 
 
 
 No cell death was observed for mucus samples without HRV, or for calcium-treated 
mucus samples with HRV. Untreated mucus with HRV showed partial cell death by 72 hours, 
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and complete cell death by 96 hours. Comparing this result to the reference standards yields 
similar behavior for an initial MoI of 0.00002, which translates to 100 HRV virions. Combining 
this value with the droplet data for untreated mucus (Chapter 4) yields an estimated 0.76 virions 
per droplet (or approximately 3 virions per 4 droplets). 
Conclusion: 
 The simulated cough system was modified to include a single-stage impactor in order to 
collect droplets produced by cough. Such impactors were developed to analyze the number and 
size of airborne contaminates: they utilize inertial impaction to deposit droplets onto plates or 
into cell-culture media. The modifications were designed to allow the detection of pathogens 
transported as small droplets (which were generated via a simulated cough maneuver). Using 
bacteria already present within the COPD sputum as proof-of-concept, the system was shown to 
functionally transport these bacteria via cough-induced droplets. Additionally, calcium-treatment 
of the mucus successfully prevented or reduced such transport.   
Viral transport was then examined by adding HRV to calcium-treated and untreated 
mucus and testing them within the simulated cough system. Transport was confirmed by 
monitoring HRV-sensitized HeLa cells for death after exposure to cough-contaminated media. 
Complete cell death was observed for the untreated mucus samples at 96 hours post-exposure, 
which corresponds to a MoI of 0.00002. No cell death was observed for calcium-treated mucus 
samples, indicating the successful prevention of airborne infection transmission. These data, 
along with the results discussed in Chapter 4, confirm the third hypothesis, indicating that 
airborne transmission of infectious disease can be reduced or eliminated through cationic 
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modification of the viscoelastic properties of mucus in such a way as to reduce or prevent droplet 
formation.  
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Chapter 6: Conclusions and further work 
Introduction: 
The goal of this research has been to study the formation and transport of pathogen-laden 
droplets from the human pulmonary system, and to investigate the impact of mucus 
viscoelasticity on that formation. This was accomplished through the exploration of a series of 
related hypotheses, which were tested through the development of bench-top models for in vitro 
assessments of the relevant processes. As the role of bioaerosols in infection transmission 
becomes increasingly prominent, new ways of thinking about the problem and new tools for 
combating it are needed. The motivation behind this work is clear: to prevent airborne 
transmission of infectious diseases (as bioaerosols) by providing the tools necessary to reliably 
screen source-treatment methods. 
 Three hypotheses were examined: 
iv) Droplet generation during tidal breathing can occur in both the 
upper airways (via surface shear) and lower airways (via film 
rupture) during inhalation, and will vary with bifurcation angle 
in the upper airways. 
v) Mucus viscoelasticity will influence droplet formation by shear 
forces, with increased stiffness yielding fewer droplets in total. 
vi) Reducing the number of bioaerosols generated decreases the 
probability of pathogen transport, and therefore the 
transmission of infection. 
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These three hypotheses were confirmed empirically, utilizing novel in vitro systems 
designed to mimic the physiological conditions of droplet generation. The first hypothesis tells 
us that bioaerosol formation during tidal breathing is more complex than recent published studies 
on expired droplets suggest, and may require treating both upper and lower airway sources, both 
of which can occur during inhalation. It also raises questions about the role of bioaerosols in 
auto-infection. The second hypothesis confirms that altering the physical properties of mucus is 
an effective method for reducing bioaerosol load. Finally, the third hypothesis shows that 
targeting bioaerosol formation can effectively prevent or reduce airborne transmission by small 
droplets. 
The small droplet hypothesis itself was established through a review of the relevant 
literature, and states that small droplets (less than a few microns in diameter) are generated in the 
airways, and exhaled to the environment, where they may persist until they are inhaled by others. 
These small droplets are produced in significantly greater quantity than larger droplets, as 
initially reported by Papineni and Rosenthal (1997)1, in contrast with the previously accepted 
notions of expelled droplets. These droplets are composed of airway lining fluid (ALF) and may 
contain pathogens and other material present in the airways. When inhaled, these droplets can 
deposit within the pulmonary system, where pathogens can establish a new infection. 
Formation and transport mechanisms: 
Two potential mechanisms for droplet formation were investigated: the long-held theory 
involving shear-induced wave-instabilities at the surface of the ALF in the upper airways, as 
demonstrated computationally by Moriarty and Grotberg (1999)2; and film rupture within 
expanding bronchioles in the lower airways (a process which occurs during inhalation), as 
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proposed by Johnson and Morawska (2009)3. The former is applicable to both tidal breathing and 
coughing. The latter has recently come to prominence due to research on expelled droplet 
number as a function of tidal breathing pattern, which supports the theory that droplets are 
formed during inhalation. 
Most studies on droplet generation in the upper airways have focused on the exhalation 
phase of tidal breathing, however based on the experiments performed by Chowdhary et al. 
(1999)4 and the computational analyses of tidal air flow in the lungs made by Green (2003)5 and 
Wang et al. (2009)6, which showed that, for tidal breathing, peak wall shear stress can occur 
along the inner wall directly past the first and second bifurcations during inhalation, the first 
hypothesis was developed. These studies indicate that droplet formation during tidal breathing in 
the upper airways is more likely to occur during inhalation, which not only has implications for 
auto-infection, but also suggests that the expelled droplet data reported by Johnson and 
Morawska may be applicable to both the lower and the upper airway mechanisms. Regardless, 
the largest number of droplets is observed during coughing, as a result of the much larger air 
velocities present (which increase wall shear stress and turbulence). Turbulence produces air 
flow velocities perpendicular to the primary airflow direction, which results in perturbations of 
the ALF and can drive wave-instability formation. 
The droplets that are formed range in size from nanometers to microns. A brief analysis 
of the system indicated that convective transport of these droplets dominated diffusive transport, 
confirming the importance of respiration flow rates. Gravitational settling was also shown to be 
negligible for droplets less than a few microns in diameter. Both droplet generation mechanisms 
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were demonstrated to be technically feasible based on droplet size, transport and time-to-escape 
the lungs. 
In vitro model development: 
To explore the proposed droplet generation mechanisms, in vitro models were developed, 
including separate systems for tidal breathing and cough air flows. These models all utilized 
optical particle counters (OPCs) to measure droplet size and number. Droplet generation was 
expected to occur in both models, although the number of droplets formed during tidal breathing 
was hypothesized to vary with bifurcation angle if it were an inhalation-based process. The 
simulated cough system was based off of research on mucus cough-clearance performed by King 
et al.7, in which a pseudo-trachea was created to model upper airway conditions. This design was 
modified for droplet generation by Watanabe et al.8 and further refined for the present research. 
First-pass measurements of the lower and upper airway models (under tidal breathing 
conditions) indicated that droplets were formed through both mechanisms. Additionally droplet 
number dependence on bifurcation angle was observed, thus confirming the first hypothesis. The 
simulated cough system produced the largest number of droplets, in line with expectations. The 
model results were in reasonable agreement with in vivo data reported in the literature (when 
exposed interfacial area and air volume were accounted for). The threshold for tidal breathing 
“super-producers”, as defined by Edwards et al.9, could be met through a number of possibilities: 
airway geometry (bifurcation angle), number and frequency of bronchiole collapse, altered ALF 
physical properties or some combination of upper and lower airway mechanisms operating in 
tandem - the specific combination may even vary by individual. 
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Mucus viscoelasticity - cationic response and effect on droplet formation: 
Based on the research of Edwards et al.9 on droplet generation, as well as the work of 
Marriott10 on mucus viscoelasticity, cationic treatment of mucus was used to investigate the 
effect of viscoelasticity on shear-driven droplet formation. The simulated cough system was 
chosen based on the large number of droplets produced and the expectation that the larger shear 
forces present during a cough represent a more strenuous test environment (and that any results 
should therefore carry over to the upper airway tidal breathing model). Due to the difficulty in 
acquiring healthy, human pulmonary mucus, several alternative sources were investigated. Based 
on comparisons to literature-reported viscoelastic properties of healthy mucus, COPD sputum 
was selected as the best choice. Published studies on the addition of cations to mucus 
demonstrated that altered viscoelasticity as a result. This was confirmed for the sputum samples, 
and used to test the second hypothesis: that the viscoelasticity of mucus would directly influence 
the number of droplets formed by surface shearing (specifically that increased stiffness would 
reduce the total number of droplets).  
Salt was added in bulk to the sputum at varying concentrations and the viscoelastic 
properties were measured. Four salts were investigated: CaCl2, MgCl2, KCl, and NaCl. At low 
cation concentrations, a decrease in the loss tangent and an increase in the complex modulus 
(compared to baseline values) were observed. The effect was greater for the divalent cations (Ca, 
Mg) compared to the monovalent cations (K, Na). These changes indicate increased overall 
mucus stiffness, and confirmed that cationic exposure alters mucus viscoelasticity. However, as 
the concentration was increased the response was reversed and ultimately the overall stiffness 
decreased (the loss tangent increased while the complex modulus decreased). Increased stiffness 
at low cation concentrations is the result of charge-shielding, as proposed by Marriott10, which 
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causes a higher entanglement density in the mucin network (an effect that was greater for 
divalent cations compared to monovalent cations).  
Cation-treated and untreated samples were placed in the simulated cough system and the 
number of droplets produced was measured. Overall, increased mucus stiffness resulted in a 
lower total number of droplets, while decreased stiffness yielded a larger number of droplets, in 
confirmation of the second hypothesis. 
Pathogen transport and transport prevention: 
The third hypothesis stated that decreasing the total number of shear-induced droplets 
(through any method, including altered mucus viscoelasticity) would reduce the opportunity for 
pathogen transmission. A modified viable Anderson Cascade Impactor (viable-ACI) was 
attached to the in vitro cough system in order to measure pathogen transport via droplets: 
droplets generated in the cough system impact a petri dish (containing chocolate-agar or cell 
culture media) within the viable ACI, transferring any pathogens contained within. 
 Untreated (“neat”) COPD sputum contained culturable bacteria which could be observed 
on agar-media plates within 48 hours (incubated). After exposure to cough-air (along with any 
droplets present), the petri dishes were removed from the viable-ACI, incubated for 48 hours and 
then observed for the presence of colony forming units (CFUs). For neat sputum, CFUs were 
detected in the cough-exposed plates, however for calcium-treated sputum, virtually no CFUs 
were seen. The calcium-treated sputum was directly plated as a control measure, and CFUs were 
observed at the low (isotonic) calcium concentration. Hence, bacteria were successfully 
transferred through the system as bioaerosols, and reduced droplet production (as a result of a 
cation-induced increase in mucus viscoelasticity) corresponded to reduced bacterial transport.  
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A similar experiment was performed with rhinovirus: the agar-media plates were 
replaced with plates containing cell-culture media. Untreated and treated sputum was spiked with 
rhinovirus at known concentrations and tested within the cough system. The cough-exposed 
media was then placed over rhinovirus-sensitized HeLa cells, which were observed for signs of 
cell-death up to 96 hours post-exposure. As a control, an untreated sputum sample with no virus 
added was also tested. The calcium treated sputum samples and the untreated sputum samples 
without virus both resulted in no observable cell death; however, for the untreated sputum 
sample with rhinovirus, exposed cell cultures first showed signs of death at 72 hours. 
Comparison to viral concentration reference data (generated from direct exposure of cells at 
varying virus concentrations) indicated a multiplicity of infection (MoI – ratio of virus to cells) 
of approximately 0.00002 for the untreated sputum samples, which indicates the initial presence 
of approximately 100 HRV virions (which is a little under 1 virion per droplet). This confirmed 
the third hypothesis. 
Implications: 
Taken together, the work confirmed that pathogens can be transported as bioaerosols 
(small droplets formed via ALF surface shearing in the upper airways); that the number of 
droplets formed is related to mucus viscoelasticity; and that mucus viscoelasticity can be altered 
by cationic addition. Tools were created to enable relatively rapid in vitro assessments of 
transmission prevention by modifying the properties of the ALF source, which was demonstrated 
to be an effective route for preventing pathogen transport. 
As noted by Roy and Milton (2004)11, the need for these tools and for a deeper 
understanding of airborne transmission in general is especially important for policy development 
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and design of hospitals and other public, indoor settings. There are also obvious applications in 
biodefense and other quarantine environments, where reducing airborne infection transmission 
would be of primary importance. However, there exist less critical, non-medical applications, 
such as particle-free laboratories, where super-producers exhaling droplets (regardless of 
pathogen presence) could be treated to prevent contamination of the lab environment. 
Open questions: 
The root cause behind super-producers remains an open question: several possible 
explanations were considered (upper versus lower airway sources, airway geometry, ALF 
physical properties), but all were demonstrated to be at least moderately feasible, and none stood 
out as an obvious choice. The most probable explanation is that some combination of these 
factors is involved, and varies from person to person and even over time for the same person, 
however more work is needed to further identify and isolate the individual contributing factors. 
Continued studies observing droplet output from the general population along with 
measurements of health-status and airway geometry would be needed to determine correlates 
between super-producers and the potential causes listed above. 
Further questions remain regarding differences in the transport behavior of different 
pathogens. For instance, at what point does pathogen size begin to play a role? Obviously very 
large bacteria with sizes over a few microns are likely to simply settle out rather than remain 
airborne, but for pathogens less than a micron in size, is there a point at which they begin to 
influence droplet aerodynamics in such a way as to alter transport potential? Furthermore, does 
their physical structure (shape, surface proteins/filaments, etc.) play a role as well? The bench-
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top models developed for this work could be used to explore a range of different pathogens (as 
well as specifically modified strains of those pathogens) to probe these remaining questions. 
Future work: 
With respect to infectious disease transmission and prevention, further research would 
involve several different routes. First and foremost, the transport experiments should be repeated 
with other bacteria and viruses – influenza, for example, would be a possible next step. This 
would be useful in addressing the questions posed previously regarding pathogen size and 
structure as well as provide further validation of the bench-top models.  
Assays for more accurately quantifying the amount of bacteria or virus transported are 
needed to improve pathogen per droplet estimates. For example, RT-PCR might be used to 
measure virus concentration in cough-exposed media. This information would be useful in 
determining the virulence or “infectiousness” of specific pathogens when coupled to in vivo 
transmission data.  
Finally, the bench-top systems should be adapted to include animal exposure models: by 
placing healthy animals downstream of bench-top bioaerosol sources (so as to allow exposure to 
contaminated airborne droplets only and prevent any other form of contact) direct airborne 
transmission and prevention could be observed. Existing influenza strains for different species 
(such as mice, pigs or ferrets) could be used to probe effects of varying breathing patterns, 
airway geometry and virulence. 
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